Navigation Links
Texas State Rep. Sylvester Turner Honored as 'Champion for Children' by The AMERIGROUP Foundation
Date:8/21/2008

thy communities by fostering access to healthcare, encouraging safe and healthy children and families, and promoting community improvement and healthy neighborhoods. For more information about the AMERIGROUP Foundation, visit http://www.amerigroupcorp.com/foundation.

Contact:

Kent Jenkins Jr.

AMERIGROUP (757) 769-7859


'/>"/>
SOURCE AMERIGROUP Foundation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Texas Cardiac Arrhythmia Institute at St. Davids Medical Center First in the Nation to Use a New Generation of Medical Robots for Complex Electrophysiology Mapping Procedures
2. Go Healthy Receives letter of Recognition from Large Texas Based Church
3. U.S. Representatives Gohmert, Granger, E.B. Johnson Praised by THCA for Helping Lead House Effort to Stop $45.6 Million Texas Medicare Cuts
4. Split Peas Soup Caf Announces the Opening Of Its El Paso, Texas Location.
5. Go Healthy Receives Letter of Recognition From the Texas Chiropractic Association
6. Video: Trinity Mother Frances and Texas Oncology-Tyler Among the First in U.S. to Boast New Cancer-Fighting Technology
7. Texas State Rep. John Davis Honored as Champion for Children by The AMERIGROUP Foundation
8. Texas Seniors Speak Out Against Medicare Advantage Cuts
9. Texas Detailed Products Today Announced the Second Generation Detail Bag: Skinceuticals Chooses the Detail Bag II Sample Case for all its Pharmaceutical Representatives
10. AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare
11. Ambulatory Services of America, Inc. Announces Joint Venture to Operate Radiation Oncology Facility in Dallas, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...NDRIA, Va., Dec. 1 Toda...t, nearly 7,000 people die each day due to HIV/A...ay of awareness and outreach to help people worldw...heme for World AIDS Day 2008 is You Can Make a D...nging people together to talk about HIV as well as...
(Date:12/1/2008)...VILLE, Ky., Dec. 1 The ... a look at his new right hand on Saturday, Novembe...splant surgeon, changed the bandages. , , "...k" Hondusky from his room at Jewish Hospital. "It...citing." , , Hondusky, a New York resident,...
(Date:12/1/2008)...ORK, Dec. 1 Amanzi Tea ( www.amanz...ed today that in celebration of its first Manhatta...ffering free "amanzi tea flu shots" made of double...December 6th, 13th and 20th from noon until four. ...immune system with the onset of winter. , ,...
(Date:12/1/2008)...onary CTA offers a low cost, non-invasive alternat...ients who are suspected of having coronary artery ...coronary artery plaques, according to a study perf... Philadelphia, PA. , The study included 31 patie...plaques that were discovered during coronary CTA. ...
Breaking Medicine News(10 mins):Health News:In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia 2Health News:Fifth U.S. Hand Transplant Patient Gets Look at New Hand 2Health News:Amanzi Tea offers free, natural 'Flu Shots' to New Yorkers 2
...as successfully demonstrated that domestic fowl, l...th's magnetic field to sense direction . As part ...g Wiltschko and Roswitha Wiltschko placed newly ha...ic field, teaching them by intensive training that...
...d an AIDS awareness project called 'Jaago' to high...society . The project, which is funded by the Bil...ful medium of Indian cinema to inform people about...e the showing of short films on the impact of the ...
...amassing an arsenal of weapons in preparation for ...pital superbugs . It infiltrates hospitals as mic... resist most antibiotics. And it kills three times... as MRSA. A research group led by Professor Nige...
...ety of Human Reproduction and Embryology today re... fertility of women with cancer and auto-immune d...irector of the Royal Womens Hospital, Melbourne, A...er pilot study had shown gonadotropin-releasing ho...
Other Medicine News:Health News:The Hospital Superbugs 2Health News:The Hospital Superbugs 3Health News:A New Therapy to Protect Cancer Patients Against Infertility 2
(Date:11/27/2008)... lymphoblastic leukemia relapse cases arise from a... , MEMPHIS, Tenn., Nov. 27 /PRNewswire-USNews...h Hospital have identified distinctive genetic cha...mphoblastic leukemia (ALL) that cause relapse. The...for ALL relapse in children and, ultimately, in ad...
(Date:11/25/2008)...USNewswire/ -- Kleinert Kutz and University of Lo...and transplant on Messina, New York resident, Jan ...and Care Center on Monday, November 24. The innov...d shortly after 9 p.m. in a record nine hours. , ...rnh/20081125/DC48555-a ) , (Photo: http://www...
(Date:11/25/2008)...al to Assess Survival of Patients Receiving Litx v...Hepatocellular Carcinoma , , BELLEVUE, Wash..., Inc. (LSO) today announced the completion of enr...t Infusion Therapy(TM) (Litx(TM)) as a treatment f...so known as hepatoma or primary liver cancer. , ...
(Date:11/24/2008)...ss Month , , Oak Brook, Ill., Nov. 24 /PRNe...strointestinal Endoscopy (ASGE) and the Pancreatic...r to raise awareness about pancreatic cancer, educ... that are available for them. , , Pancreati...ths in the U.S. In 2008, an estimated 37,680 Ameri...
Breaking Medicine Technology:St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 2St. Jude Identifies Genomic Causes of a Certain Type of Leukemia Relapse 3Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 2Kleinert Kutz Hand Surgeons Perform Fifth U.S. Hand Transplant in Record Time at Jewish Hospital Hand Care Center 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 2Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 3Light Sciences Oncology Completes Patient Enrollment in Phase 3 Clinical Trial of Litx as a Treatment for Hepatocellular Carcinoma 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 2ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 3ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 4ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 5ASGE and The Pancreatic Cancer Action Network Partner to Raise Awareness About Pancreatic Cancer 6Trans Fat Labeling Gets Tricky 22932 1Trans Fat Labeling Gets Tricky 22932 2Trans Fat Labeling Gets Tricky 22932 3Trans Fat Labeling Gets Tricky 22932 4Trans Fat Labeling Gets Tricky 22932 5Cadient Group President and CEO Stephen Wray Named 2008 Ernst 26 Young Entrepreneur Of The Year 28R 29 in Greater Philadelphia Region 22928 1Cadient Group President and CEO Stephen Wray Named 2008 Ernst 26 Young Entrepreneur Of The Year 28R 29 in Greater Philadelphia Region 22928 2Cadient Group President and CEO Stephen Wray Named 2008 Ernst 26 Young Entrepreneur Of The Year 28R 29 in Greater Philadelphia Region 22928 3China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County Guangxi Province 6301 1China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County Guangxi Province 6301 2China Biologic Products Announces Approval for Setting Up a New Plasma Collection Station in Pu Bei County Guangxi Province 6301 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 2546 1Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 2546 2Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 2546 3Peregrine Pharmaceuticals Doses First Patient in Phase II Trial of Bavituximab in Patients With Non Small Cell Lung Cancer 2546 4
...resented at EULAR Confirms Efficacy with Either Ev...n, 14 June 2007 - 7:00 am CET - New pivotal data,(...ean Congress of,Rheumatology (EULAR) show that Cim...free anti-TNF, combined with methotrexate,therapy ... signs,and symptoms of active rheumatoid arthritis...
...-B(R) significantly reduced signs and symptoms of ...linical and,biological activity at 76 weeks-, ROCK...- Human,Genome Sciences, Inc. today announced the ...hat LymphoStat-B(R) (belimumab),significantly redu...ures, was well tolerated and improved quality of l...
Other Medicine Technology:Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 2Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 3Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 4Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 5Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 6Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 7Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid,Arthritis 8Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 2Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 3Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 4Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 5Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 6Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 7Human Genome Sciences Reports That a Phase 2 Study of LymphoStat-B,Showed Significant Reductions in Disease Activity in Patients with,Active Systemic Lupus Erythematosus 8
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
...UP Laboratories is a national reference laboratory...esearch and development. ARUP offers an extensive ...ts in clinical and anatomic pathology. Owned by th...nclude more than half of the nation's university t...
Medicine Products: